DK0938900T3 - Midler til forebyggelse/behandling af stomatitis - Google Patents

Midler til forebyggelse/behandling af stomatitis

Info

Publication number
DK0938900T3
DK0938900T3 DK97928459T DK97928459T DK0938900T3 DK 0938900 T3 DK0938900 T3 DK 0938900T3 DK 97928459 T DK97928459 T DK 97928459T DK 97928459 T DK97928459 T DK 97928459T DK 0938900 T3 DK0938900 T3 DK 0938900T3
Authority
DK
Denmark
Prior art keywords
stomatitis
prevention
treatment
zinc
remeties
Prior art date
Application number
DK97928459T
Other languages
English (en)
Inventor
Masaaki Hirano
Shiro Katayama
Original Assignee
Zeria Pharm Co Ltd
Hamari Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharm Co Ltd, Hamari Chemicals Ltd filed Critical Zeria Pharm Co Ltd
Application granted granted Critical
Publication of DK0938900T3 publication Critical patent/DK0938900T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58Metal complex; Coordination compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
DK97928459T 1996-07-03 1997-06-25 Midler til forebyggelse/behandling af stomatitis DK0938900T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19164096A JP3877807B2 (ja) 1996-07-03 1996-07-03 口内炎治療・予防剤

Publications (1)

Publication Number Publication Date
DK0938900T3 true DK0938900T3 (da) 2006-09-04

Family

ID=16278026

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97928459T DK0938900T3 (da) 1996-07-03 1997-06-25 Midler til forebyggelse/behandling af stomatitis

Country Status (11)

Country Link
US (1) US6169083B1 (da)
EP (1) EP0938900B1 (da)
JP (1) JP3877807B2 (da)
KR (1) KR20000022204A (da)
AT (1) ATE326232T1 (da)
AU (1) AU713337B2 (da)
DE (1) DE69735892T2 (da)
DK (1) DK0938900T3 (da)
ES (1) ES2264166T3 (da)
PT (1) PT938900E (da)
WO (1) WO1998001146A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010025027A1 (en) * 2000-03-07 2001-09-27 Sonis Stephen T. Inhibition of ceramide for the prevention and treatment of oral mucositis induced by antineoplastic drugs or radiation
EP1285660A4 (en) * 2000-05-31 2003-07-09 Hamari Chemicals Ltd ZINC SUPPLEMENTARY COMPOSITIONS FOR ORAL ADMINISTRATION
TWI280136B (en) * 2003-05-30 2007-05-01 Lytone Enterprise Inc Composition containing dipeptide of histidine and alanine for reducing uric acid
JP5390767B2 (ja) * 2005-03-11 2014-01-15 豊彦 宅重 細菌性口腔内疾患の治療用組成物、洗浄用処理液、止血用処理液、及び、細菌性口腔内疾患の治療方法
JP5205618B2 (ja) * 2007-06-19 2013-06-05 学校法人日本大学 抗菌剤
JP2009235053A (ja) * 2008-03-05 2009-10-15 Kyowa Chem Ind Co Ltd 口内炎予防乃至治療薬
WO2016057910A1 (en) * 2014-10-09 2016-04-14 Di Rocco Richard J +l-carnosine zinc formulations and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028921A (ja) * 1983-07-27 1985-02-14 Kaneshiro Nagai 炎症治癒促進剤
JPS61186322A (ja) * 1985-02-13 1986-08-20 Nippon Univ 免疾調節剤
JPS6314728A (ja) * 1986-07-03 1988-01-21 Zeria Shinyaku Kogyo Kk 肝障害の予防、治療剤
JPS63229058A (ja) * 1987-03-17 1988-09-22 大鳥 泰雅 骨形成材料の製法
JPH07116160B2 (ja) * 1987-08-10 1995-12-13 浜理薬品工業株式会社 結晶性l−カルノシン亜鉛錯体およびその製造法
CA2117199C (en) * 1991-09-09 2004-12-28 Jurgen Michaelis Method for the treatment of the complications and pathology of diabetes
US5380530A (en) 1992-12-29 1995-01-10 Whitehill Oral Technologies Oral care composition coated gum
FR2701948B1 (fr) * 1993-02-22 1996-07-26 Exsymol Sa Produit de couplage de l'histamine ou l'histamine méthyl-substituée et d'un acide aminé, procédé de préparation et applications thérapeutiques, cosmétologiques et agroalimentaires.
AUPN784796A0 (en) * 1996-02-02 1996-02-22 Bellara Medical Products Limited Supplementation of glucocorticoids

Also Published As

Publication number Publication date
EP0938900A1 (en) 1999-09-01
WO1998001146A1 (fr) 1998-01-15
EP0938900B1 (en) 2006-05-17
PT938900E (pt) 2006-07-31
ATE326232T1 (de) 2006-06-15
JPH1017490A (ja) 1998-01-20
AU713337B2 (en) 1999-12-02
US6169083B1 (en) 2001-01-02
AU3274597A (en) 1998-02-02
DE69735892D1 (de) 2006-06-22
KR20000022204A (ko) 2000-04-25
DE69735892T2 (de) 2006-09-28
ES2264166T3 (es) 2006-12-16
JP3877807B2 (ja) 2007-02-07
EP0938900A4 (en) 2004-03-31

Similar Documents

Publication Publication Date Title
DK0572437T3 (da) 2,4-diaminoquinazolinderivater til forøgelse af antitumorvirkning
GB2368796A (en) Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
IL147017A0 (en) TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES
TR200301846T2 (tr) Cripto bloke edici Antikorlar ve bu antikorların kullanımları.
NO20014560L (no) Quinasoliner og terapautisk anvendelse derav
ATE306281T1 (de) Antivirales mittel in kombination mit strahlentherapie zur verwendung in der behandlung von krebs
MX9707022A (es) Derivados de fenilo trisustituidos.
PL322732A1 (en) Pharmaceutic agent containing n-chlorophenyl carbaminates and n-chlorophenyl thiocarbaminates for inhibiting development of viruses and carcinoma
IL97055A0 (en) Pharmaceutical compositions for sensitizing tumor cells comprising quinazolinedione derivatives
DK0938900T3 (da) Midler til forebyggelse/behandling af stomatitis
FI934565A (fi) Pyrimidinderivat foer att oeka antitumoeraktiviteten
DE69533873D1 (de) Krebstherapie mit lymphotoxin
PT971710E (pt) Utilizacao de queleritrina e radiacao para terapia de tumores
NO953349L (no) Kombinasjonsterapi av human cancer med cisplatin/tamoxifen
MD798G2 (ro) Metoda de tratament a cancerului mamar
CA2259997A1 (en) Remedies and preventives for stomatitis
MX9200725A (es) Tratamiento de cancer esofagico. tratamiento de cancer esofagico.
IL164356A (en) Use of alpha- bromo or alpha-chloro acryloyl distamycin derivatives in the preparation of medicaments for treating cancer
EP0139005A4 (en) ANTITUMOR COMPOSITION, METHOD FOR TREATING TUMORS, AND USE OF THE COMPOSITION FOR TREATING TUMORS.
ATE102832T1 (de) Regionale chemotherapie mit 4hydroperoxycyclophosphamid.
AU6514299A (en) Methods for the treatment of cancer using cytokines in combination with low level doses of chemotherapy and/or radiotherapy
ITMI980179A1 (it) Proteine ricombinanti derivate da hgf e msp
MXPA02000485A (es) 2-amino-benzoxazinonas para el tratamiento del virus de herpes simple.
DE58904510D1 (de) Optisch reines dexniguldipin und dessen derivate zur behandlung von tumorerkrankungen.
WO2001073056A3 (en) Regulation of human oxoprolinase-like enzyme